Reported 1 day ago
Wells Fargo reports that Abbott and DexCom have settled their patent litigation in the U.S. and Europe with a ten-year cross-license agreement, a development they anticipated. This agreement grants both companies worldwide royalty-free licenses to specific patents related to analyte sensing.
Source: YAHOO